Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 3/20 | 0.50 |
| ▸ | NR1H3 | Q13133 | 3/20 | 0.50 |
| ▸ | AHR | P35869 | 3/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.41 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17336869 | 0.96 | AHR (0.44) | NR1H2NR1H3AHRSMN1; SMN2ABCG2 | |
| SCHEMBL17336613 | 0.90 | AHR (0.48) | NR1H2NR1H3AHRSMN1; SMN2 | |
| SCHEMBL29035848 | 0.90 | NR1H2 (0.60) | NR1H2NR1H3SMN1; SMN2NR1H4 | |
| SCHEMBL13921788 | 0.88 | NR1H2 (0.57) | NR1H2NR1H3AHRSMN1; SMN2NR1H4 | |
| SCHEMBL2818083 | 0.85 | NR1H3 (0.57) | NR1H2NR1H3SMN1; SMN2 | |
| SCHEMBL17336636 | 0.81 | ACHE (0.46) | AHRSMN1; SMN2 | |
| SCHEMBL13936046 | 0.80 | SMN1; SMN2 (0.56) | NR1H2NR1H3SMN1; SMN2 | |
| SCHEMBL4520381 | 0.80 | NR1H2 (0.50) | NR1H2NR1H3AHR | |
| SCHEMBL13936045 | 0.80 | SMN1; SMN2 (0.56) | NR1H2NR1H3SMN1; SMN2 | |
| SCHEMBL17336858 | 0.80 | AHR (0.42) | AHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9113536-B2 | Electroluminescent device | BASF SE (DE) | 2015-08-18 | — | — | US | disclosed |
| US-9113536-B2 | Electroluminescent device | BASF SE (DE) | 2015-08-18 | — | — | US | disclosed |
| US-9113536-B2 | Electroluminescent device | BASF SE (DE) | 2015-08-18 | — | — | US | disclosed |
| CN-101171239-B | Electroluminescent device | CIBA SC HOLDING AG | 2013-08-14 | — | — | CN | disclosed |
| US-20090066231-A1 | Electroluminescent device | UDC IRELAND LIMITED (IE) | 2009-03-12 | — | — | US | disclosed |
| US-20090066231-A1 | Electroluminescent device | UDC IRELAND LIMITED (IE) | 2009-03-12 | — | — | US | disclosed |
| US-20090066231-A1 | Electroluminescent device | UDC IRELAND LIMITED (IE) | 2009-03-12 | — | — | US | disclosed |
| CN-101171239-A | Electroluminescent device | CIBA SC HOLDING AG (CH) | 2008-04-30 | — | — | CN | disclosed |
| EP-1874740-A1 | ELECTROLUMINESCENT DEVICE | CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement (CH) | 2008-01-09 | — | — | EP | disclosed |
| WO-2006114377-A1 | ELECTROLUMINESCENT DEVICE | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-11-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090066231-A1 | Electroluminescent device | CD99, TEC, TYR | NR1H2 1883/4885NR1H3 1550/4885AHR 629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.